Lauren Pearson
No Rating Available
(Learn About Our Rating System)

Lauren Pearson, DO, MPH

Languages spoken: English

Dr. Pearson is an Associate Professor (Clinical) in the Department of Pathology at the University of Utah. She serves as the Chief Medical Officer for ARUP at University of Utah in Salt Lake City. She is board certified in anatomic and clinical pathology.

Dr. Pearson’s academic interests include pathology education, quality control, analytical interferences, instrumentation, and laboratory stewardship.

Specialties

  • Pathology

Board Certification

American Board of Pathology (Anatomic & Clinical)
National Board of Osteopathic Medical Examiners

Dr. Pearson is an Associate Professor (Clinical) in the Department of Pathology at the University of Utah. She serves as the Chief Medical Officer for ARUP at University of Utah in Salt Lake City. She is board certified in anatomic and clinical pathology.

Dr. Pearson’s academic interests include pathology education, quality control, analytical interferences, instrumentation, and laboratory stewardship.

Board Certification and Academic Information

Academic Departments Pathology -Associate Professor (Clinical)
Board Certification
American Board of Pathology (Anatomic & Clinical)
National Board of Osteopathic Medical Examiners

Education history

Undergraduate Molecular, Cell and Developmental Biology - University of California, Santa Cruz B.S.
Professional Medical Osteopathic Medicine/Community Health Track - Touro University California D.O., M.P.H.
Residency Anatomic and Clinical Pathology - University of Vermont College of Medicine/University of Vermont Medical Center Resident
Chief Resident Anatomic and Clinical Pathology - University of Vermont College of Medicine/University of Vermont Medical Center Chief Resident

Selected Publications

Journal Article

  1. Layfield LJ, Pearson L, Walker BS, White SK, Schmidt R (2018). Diagnostic Accuracy of Fine-Needle Aspiration Cytology for Discrimination of Squamous Cell Carcinoma from Adenocarcinoma in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Acta cytologica, 62(5-6), 318-326.
  2. Pearson L, Factor RE, White SK, Walker BS, Layfield LJ, Schmidt R (2018). Rapid On-Site Evaluation of Fine-Needle Aspiration by Non-Cytopathologists: A Systematic Review and Meta-Analysis of Diagnostic Accuracy Studies for Adequacy Assessment. Acta cytologica, 62(4), 244-252.
  3. Schumacher JA, Holgard VD, Sial F, Pearson LN, Patel JL, Karner K (2020). Detection and Quantification of FLT3 Internal Tandem Duplication Mutations Do Not Vary Significantly Between Whole Blood and Blast-Enriched Samples. American journal of clinical pathology, 153(2), 251-257.
  4. Pearson LN, Miller JM, Lunde JH, Bryant RJ, Lewis MR, Tang M (2019). Combined Pathology-Driven Algorithmic Testing and Integrated Reporting for Bone Marrow Examination. Archives of pathology & laboratory medicine, 143(6), 732-737.
  5. Goold E, Pearson L, Johnson L (2020). Can fecal calprotectin serve as a screen for necrotizing enterocolitis in infants?. Clinical biochemistry,
  6. Schmidt RL, Pearson L (2019). Estimating the cost of quality of errors in the analytical phase. Clinica chimica acta; international journal of clinical chemistry, 495, 60-66.
  7. Schmidt RL, Pearson L (2019). Quality control optimization part II: A method to optimize the accuracy of laboratory quality control. Clinica chimica acta; international journal of clinical chemistry, 495, 233-238.
  8. Schmidt RL, Pearson L (2019). Quality control optimization part I: Metrics for evaluating predictive performance of quality control. Clinica chimica acta; international journal of clinical chemistry, 495, 174-184.
  9. Schmidt RL, Pearson L (2019). Is your assay stable? Using process stability and capability to evaluate assay performance. Clinica chimica acta; international journal of clinical chemistry, 490, 28-33.
  10. Schmidt RL, Walker BS, Pearson L (2018). Quality control limits: Are we setting them too wide?. Clinica chimica acta; international journal of clinical chemistry, 486, 329-334.
  11. Schmidt RL, Moore RA, Pearson L (2020). The costs and benefits of cross-level quality control rules. Clinica chimica acta; international journal of clinical chemistry, 510, 697-702.
  12. Okoye NC, Barker AP, Curtis K, Orlandi RR, Snavely EA, Wright C, Hanson KE, Pearson L (2021). Performance Characteristics of BinaxNOW COVID-19 Antigen Card for Screening Asymptomatic Individuals in a University Setting. Journal of clinical microbiology, 59(4),
  13. Metcalf RA, Calvaresi E, Tonna JE, Blaylock R, Pearson (2019). Severe intravascular hemolysis following extracorporeal right ventricular assist device placement. Transfusion, 59(4), 1178-1179.
  14. Walker BS, Pearson LN, Schmidt R (2020). An Analysis of Multirules for Monitoring Assay Quality Control. Laboratory medicine, 51(1), 94-98.
  15. Pearson LN, Schmidt R (2019). Adoption of Evidence-Based Medicine in Clinical Laboratory Science: A Survey of the Prevalence of Systematic and Narrative Reviews. Laboratory medicine, 50(3), 223-228.
  16. Lehman CM, Pearson L, Salmond J, Raphael K, Schmidt R (2019). A Reflex Protocol for Creatinine Testing Reduces Costs and Maintains Patient Safety. Laboratory medicine, 50(2), 202-207.
  17. Adams A, Straseski JA, Lehman CM, Pearson L (2019). Peritoneal and Pleural Fluid Chemistry Measurements Performed on Three Chemistry Platforms. Laboratory medicine, 50(2), 145-149.
  18. Pearson LN, Layfield LJ, Schmidt R (2018). Cost-effectiveness of rapid on-site evaluation of the adequacy of FNA cytology samples performed by nonpathologists. Cancer cytopathology, 126(10), 839-845.
  19. De Luca-Johnson J, Ninfea JI, Pearson L, Conant J, Bryant R, Zakai NA, Tang M (2016). Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature. Case reports in medicine, 2016, 8324791.
  20. Pearson LN, Moser KA, Schmidt R (2020). D-Dimer Varies Widely Across Instrument Platforms and is Not a Reliable Indicator of Periprosthetic Joint Infections. Arthroplasty today, 6(4), 686-688.
  21. Gruzdys V, Cahoon K, Pearson L, Lehman C (2019). Method Verification Shows a Negative Bias between 2 Procalcitonin Methods at Medical Decision Concentrations. The journal of applied laboratory medicine, 4(1), 69-77.
  22. Pearson LN, Schmidt RL, Cahoon K, Pelt C (2020). Reliability of Total Nucleated Cell Counts in the Setting of Hip Arthroplasty. The journal of applied laboratory medicine, 6(3), 679-687.
  23. Pearson LN, Johnson SA, Greene DN, Chambliss AB, Farnsworth CW, French D, Herman DS, Kavsak PA, Merrill AE, Lo SM, Lyon ME, SoRelle JA, Schmidt R (2021). Side-Effects of COVID-19 on Patient Care: An INR Story. The journal of applied laboratory medicine, 6(4), 953-961.
  24. Genzen JR, Souers RJ, Pearson LN, Manthei DM, Chambliss AB, Shajani-Yi Z, Miller W (2022). Reported Awareness and Adoption of 2021 Estimated Glomerular Filtration Rate Equations Among US Clinical Laboratories, March 2022. JAMA, 328(20), 2060-2062.
  25. Pandya V, Nguyen Sorenson AHT, Jones E, Young BA, Pearson L (2023). Spirited away: Can ethanol testing in add-on orders provide meaningful results?. Clinical biochemistry, 115, 97-102.
  26. Potter S, Rudolf JW, Pearson L (2024). Rainbow phlebotomy collection and urine aliquots for emergency department add-on testing in the era of pandemic-driven supply shortages. Laboratory medicine,
  27. Mathewson NJ, Pearson LN, Doyle (2023). Abnormal Hb A1c Result from a Diabetic Patient Leads to Unexpected Diagnosis. Clinical chemistry, 69(7), 684-687.
  28. Baryeh K, Mathewson NJ, Pearson L (2025). Blood Cell Agglutination Interference in Complete Blood Count Analysis. Clinical Chemistry, 71(6), 629-631.
  29. Nelson HA, Condie C, Doyle K, Rudolf JW, Pearson L (2025). On-Cell Stability of Digoxin, Lithium, Phenytoin, Valproic Acid, and Vancomycin for Therapeutic Drug Monitoring. The journal of applied laboratory medicine, 10(5), 1285-1291.
  30. Baryeh K, Mathewson NJ, Pearson L (2025). Blood Cell Agglutination Interference in Complete Blood Count Analysis. Clinical chemistry, 71(6), 629-631.
  31. Gruzdys V, Cahoon K, Pearson L, Raphael K (2022). Measurement of Urinary Ammonium Using a Commercially Available Plasma Ammonium Assay. Kidney360, 3(5), 926-932.
  32. Sharma A, Greene DN, Chambliss AB, Farnsworth CW, French D, Herman DS, Kavsak PA, Merrill AE, Margaret Lo SY, Lyon ME, Winston-McPherson G, Pearson LN, SoRelle JA, Waring AC, Schmidt R (2021). The effect of the Covid-19 shutdown on glycemic testing and control. Clinica chimica acta; international journal of clinical chemistry, 519, 148-152.

Letter

  1. Moser KA, Pearson LN, Pelt CE, Olson JD, Goodwin AJ, Isom JA, Harris NS, Pham HP, Smock KJ, Unold D, VanSandt AM, Volod O, Chen (2020). Letter to the Editor on "The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria". The Journal of arthroplasty, 35(9), 2682-2683.
  2. Genzen JR, Souers RJ, Pearson LN, Manthei DM, Chambliss AB, Shajani-Yi Z, Miller W (2023). An Update on Reported Adoption of 2021 CKD-EPI Estimated Glomerular Filtration Rate Equations. Clinical chemistry, 69(10), 1197-1199.
  3. Maucione C, McLamb N, Zaydman MA, Pearson LN, Metcalf RA, Spies N (2025). Intravenous fluid contamination in complete blood counts may lead to unnecessary red blood cell transfusions. Transfusion, 65(10), 1996-1998.
  4. Maucione C, McLamb N, Zaydman MA, Pearson LN, Metcalf RA, Spies N (2025). Intravenous fluid contamination in complete blood counts may lead to unnecessary red blood cell transfusions. Transfusion, 65(10), 1996-1998.

Video/Film/CD/Web/Podcast

  1. Tidwell M, Hill (2024). Women in White Coats Episode 19: Dr. Lauren Pearson.